ATE185811T1 - Verfahren zur herstellung von n-acyl-5- fluorocytidinderivaten - Google Patents

Verfahren zur herstellung von n-acyl-5- fluorocytidinderivaten

Info

Publication number
ATE185811T1
ATE185811T1 AT95112521T AT95112521T ATE185811T1 AT E185811 T1 ATE185811 T1 AT E185811T1 AT 95112521 T AT95112521 T AT 95112521T AT 95112521 T AT95112521 T AT 95112521T AT E185811 T1 ATE185811 T1 AT E185811T1
Authority
AT
Austria
Prior art keywords
acyl
producing
pref
methanol
formula
Prior art date
Application number
AT95112521T
Other languages
English (en)
Inventor
Herbert Robert Brinkmann
Panayiotis Kalaritis
John Francis Morissey
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE185811T1 publication Critical patent/ATE185811T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95112521T 1994-08-26 1995-08-09 Verfahren zur herstellung von n-acyl-5- fluorocytidinderivaten ATE185811T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/296,842 US5476932A (en) 1994-08-26 1994-08-26 Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives

Publications (1)

Publication Number Publication Date
ATE185811T1 true ATE185811T1 (de) 1999-11-15

Family

ID=23143805

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95112521T ATE185811T1 (de) 1994-08-26 1995-08-09 Verfahren zur herstellung von n-acyl-5- fluorocytidinderivaten

Country Status (9)

Country Link
US (1) US5476932A (de)
EP (1) EP0698611B1 (de)
JP (1) JP3986574B2 (de)
KR (1) KR100335542B1 (de)
CN (1) CN1053194C (de)
AT (1) ATE185811T1 (de)
DE (1) DE69512851T2 (de)
DK (1) DK0698611T3 (de)
ES (1) ES2138691T3 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
KR100631754B1 (ko) * 2000-08-09 2006-10-09 주식회사 코오롱 Ｎ-알킬옥시카르보닐-5-플루오로사이토신 유도체 및 그의제조방법
AU2003234567A1 (en) 2002-05-15 2003-12-02 Janssen Pharmaceutica N.V. N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
DK1706414T3 (da) * 2003-12-22 2008-10-13 Hoffmann La Roche Fremgangsmåde til fluorcytidinderivater
CN100383128C (zh) * 2004-02-23 2008-04-23 上海迪赛诺医药发展有限公司 N4－氧羰基胞嘧啶衍生物及制备方法与应用
US20050192433A1 (en) * 2004-02-26 2005-09-01 Mitsui Chemicals, Inc. Metallic salt of N4-acylcytidine derivatives, and a method for producing N4-acylcytidine derivatives using the same
EP1845974A1 (de) 2005-01-21 2007-10-24 Astex Therapeutics Limited Pharmazeutische verbindungen
NZ556673A (en) 2005-02-03 2010-03-26 Gen Hospital Corp Method for treating gefitinib and/or erlotinib resistant cancer with an EGFR inhibitor
AU2006228581A1 (en) * 2005-04-01 2006-10-05 F. Hoffmann-La Roche Ag Method for administration of capecitabine
CN100569790C (zh) * 2005-07-15 2009-12-16 上海奥锐特国际贸易有限公司 合成n4-酰基-5＇-脱氧-5-氟胞苷衍生物的方法
EP3488866A1 (de) 2005-11-04 2019-05-29 Wyeth LLC Antineoplastische kombinationen mit mtor-inhibitor, herceptin und/oder hki-272
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
CN100425617C (zh) * 2006-10-31 2008-10-15 浙江海正药业股份有限公司 一种含氟嘧啶类化合物烷氧羰酰化的方法
ITMI20070435A1 (it) 2007-03-05 2008-09-06 Innovate Biotechnology Srl 2',3'-di-o-acil-5-fluoronucleosidi
WO2009022435A1 (ja) * 2007-08-15 2009-02-19 Japan Absorbent Technology Institute 吸収体製品およびその製造方法
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
KR101013312B1 (ko) * 2007-11-19 2011-02-09 한미홀딩스 주식회사 카페시타빈의 제조방법 및 이에 사용되는 β-아노머가강화된 트리알킬카보네이트 화합물의 제조방법
AR064165A1 (es) 2007-12-06 2009-03-18 Richmond Sa Com Ind Y Financie Un procedimiento para la preparacion de capecitabina e intermediarios utilizables en dicho procedimiento
WO2009082844A1 (fr) * 2007-12-28 2009-07-09 Topharman Shanghai Co., Ltd Dérivé hydroxyle de la capécitabine, ses procédés de préparation et ses utilisations pour préparer la capécitabine
WO2009082846A1 (fr) * 2007-12-28 2009-07-09 Topharman Shanghai Co., Ltd. Dérivé hydroxyle de la capécitabine, ses procédés de préparation et ses utilisations pour préparer la capécitabine
CN101469008B (zh) * 2007-12-29 2013-08-07 上海特化医药科技有限公司 卡培他滨羟基衍生物、其制备方法和用于制备卡培他滨
WO2009094847A1 (fr) * 2007-12-28 2009-08-06 Topharman Shanghai Co., Ltd. Dérivé hydroxyle de capécitabine, procédés de préparation et d' utilisation de la capécitabine
KR20090122955A (ko) * 2008-01-03 2009-12-01 플러스 케미칼스, 에스.에이. 카페시타빈의 제조 방법
DK2300489T3 (en) * 2008-06-06 2016-02-15 Neurmedix Inc PROCESSES FOR PREPARING 17-alkynyl-7-HYDROXY STEROIDS AND RELATED COMPOUNDS
ES2531322T3 (es) 2008-06-17 2015-03-13 Wyeth Llc Combinaciones antineoplásicas que contienen HKI-272 y vinorelbina
EP3175853B1 (de) 2008-08-04 2023-11-01 Wyeth LLC Antineoplastische kombinationen aus neratinib und capecitabin
PT3000467T (pt) 2009-04-06 2023-03-30 Wyeth Llc Regime de tratamento utilizando neratinib para o cancro de mama
WO2011067588A1 (en) 2009-12-04 2011-06-09 Generics [Uk] Limited Cyclic sulphinyl esters of cytidine
WO2011104540A1 (en) 2010-02-24 2011-09-01 Generics [Uk] Limited One step process for the preparation of capecitabine
CN102260309B (zh) * 2010-05-24 2014-10-22 重庆福安药业(集团)股份有限公司 一种高纯度卡培他滨的制备方法
DK2750683T4 (da) 2011-10-03 2021-04-12 Croda Int Plc Nanopartikler, fremgangsmåde til fremstilling og anvendelse deraf som bærer for amfipatiske eller hydrofobe molekyler inden for medicin, herunder cancerbehandling, og i fødevarerelaterede forbindelser
TWI560195B (en) * 2012-01-13 2016-12-01 Pharmaessentia Corp Novel synthesis of 5-deoxy-5'-fluorocytidine compounds
WO2014163558A1 (en) 2013-04-01 2014-10-09 Moreinx Ab Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds
CN104926901B (zh) * 2015-06-15 2018-04-20 广安凯特制药有限公司 一种卡培他滨关键中间体的合成方法
US11034667B2 (en) 2017-01-09 2021-06-15 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
US11584733B2 (en) 2017-01-09 2023-02-21 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
US10435429B2 (en) 2017-10-03 2019-10-08 Nucorion Pharmaceuticals, Inc. 5-fluorouridine monophosphate cyclic triester compounds
WO2019139921A1 (en) 2018-01-09 2019-07-18 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
AU2019207626B2 (en) 2018-01-10 2023-10-05 Nucorion Pharmaceuticals, Inc. Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
CN111801339B (zh) * 2018-01-19 2025-06-24 纽科利制药公司 5-氟尿嘧啶化合物
EP3669890A1 (de) 2018-12-18 2020-06-24 Croda International PLC Filamentöse nanopartikel mit impfstoffadjuvanswirkung
WO2021011692A1 (en) 2019-07-17 2021-01-21 Nucorion Pharmaceuticals, Inc. Cyclic deoxyribonucleotide compounds
EP4143199B1 (de) 2020-04-21 2025-11-19 Ligand Pharmaceuticals, Inc. Nukleotid-prodrug-verbindungen
WO2021216431A1 (en) 2020-04-21 2021-10-28 Ligand Pharmaceuticals, Inc. Benzyloxy phosph(on)ate compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982000997A1 (en) * 1980-09-22 1982-04-01 Johannson R Carriage assembly with shiftable forks
CA1327358C (en) * 1987-11-17 1994-03-01 Morio Fujiu Fluoro cytidine derivatives
AU671491B2 (en) * 1992-12-18 1996-08-29 F. Hoffmann-La Roche Ag N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
TW254946B (de) * 1992-12-18 1995-08-21 Hoffmann La Roche

Also Published As

Publication number Publication date
EP0698611B1 (de) 1999-10-20
CN1053194C (zh) 2000-06-07
CN1126726A (zh) 1996-07-17
US5476932A (en) 1995-12-19
DK0698611T3 (da) 2000-03-27
JPH0859687A (ja) 1996-03-05
EP0698611A1 (de) 1996-02-28
KR960007610A (ko) 1996-03-22
DE69512851D1 (de) 1999-11-25
ES2138691T3 (es) 2000-01-16
JP3986574B2 (ja) 2007-10-03
KR100335542B1 (ko) 2002-11-08
DE69512851T2 (de) 2000-05-04

Similar Documents

Publication Publication Date Title
DE69512851D1 (de) Verfahren zur Herstellung von N-Acyl-5-Fluorocytidinderivaten
DE50305141D1 (de) Verfahren zur herstellung von metallkomplexen
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
ATE235473T1 (de) Verfahren zur herstellung von triazolinthion- derivaten
DE59705405D1 (de) Verfahren zur herstellung von fluor enthaltenden verbindungen
DE59810363D1 (de) Verfahren zur herstellung von triazolinthion-derivaten
DE3773535D1 (de) Verfahren zur herstellung von alpha-substituierten gamma-butyrolactonen.
ATE126193T1 (de) Verfahren zur herstellung von ungesättigten ethern.
ATE156134T1 (de) Verfahren zur herstellung von alkylpolyglukosiden
ATE271057T1 (de) Verfahren zur herstellung von alendron-säure
ATE193009T1 (de) Verfahren zur herstellung von 2,6-dichlor-4- bromoaniliden
ATE384067T1 (de) Verfahren zur herstellung von 3-cephemderivaten
ATE151075T1 (de) Verfahren zur herstellung von einer tricyclischen verbindung
ATE219052T1 (de) Verfahren zur herstellung von 2-acetylthio-3- phenyl-propionsäure und deren salzen
ATE190306T1 (de) Verfahren zur herstellung von 2-chlor-5- aminomethylpyridin
ATE171932T1 (de) Verfahren zur herstellung von 4-halo- 2'nitrobutyrophenon
ATE125264T1 (de) Lösungsmittelfreies verfahren zur herstellung von 1,2:5,6-di-o-isopropylidene-3-o-3'-(n',n'- dimethylamino-n- propyl)-alpha,d-glucofuranose und 1,2:5,6-di-o-isopropylidene- 3-o-heptyl- alpha, d-glucofuranose und selektive hydrolyse davon.
ATE202350T1 (de) Verfahren zur herstellung von sulfonylharnstoffderivaten
ATE203525T1 (de) Verfahren zur herstellung von 4-amino-1,2,4- triazolen
ATE251135T1 (de) Verfahren zur herstellung von 1-substituierten pyrrol-3-carbonsäure-derivaten
DE69410073D1 (de) Verfahren zur Herstellung von 2-Perfluoroalkyl-3-oxazolin-5-one
ATE167674T1 (de) Verfahren zur herstellung von l-ascorbinsäure
ATE135369T1 (de) Chemisches verfahren zur herstellung des antibiotikums l 17392 (deglukoteicoplanin) und dessen salze
DE69810924D1 (de) Verfahren zur herstellung von arylmalonaten
ATE253553T1 (de) Verfahren zur herstellung von 2- alkylthiobenzonitril-derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification